𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alternating Treatment with S-1 Plus Low-Dose Cisplatin and S-1 Alone for Advanced Gastric Cancer

✍ Scribed by Kazuhito Mita; Hideto Ito; Masato Fukumoto; Ryo Murabayashi; Kazuya Koizumi; Takashi Hayashi; Hiroyuki Kikuchi; Tadashi Kagaya


Book ID
107412146
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
163 KB
Volume
15
Category
Article
ISSN
1091-255X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impacts of fluorouracil-metabolizing enz
✍ Wasaburo Koizumi; Satoshi Tanabe; Mizutomo Azuma; Kenji Ishido; Ken Nishimura; T πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 267 KB

## Abstract A phase III trial of S‐1 plus cisplatin (SP) __versus__ S‐1 alone, for first‐line treatment of advanced gastric cancer (SPIRITS trial), has shown that overall survival was better in patients treated with SP than with S‐1 alone. In the present retrospective biomarker study, we aimed to d